The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market
Founded in 2019 by Shubhendra Singh Thakur and Deovrat Begde, ErlySign develops solutions for early detection of oral cancer
The company also claims to offer India’s first salivary biomarker based test which can identify pre- cancerous conditions
Healthtech startup ErlySign has secured INR 16 Cr (around $1.8 Mn) in Pre-Series A funding round from Ashish Kacholia to further develop its cancer diagnostic solutions.
The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market, the startup said in its statement.